VistaGen Therapeutics Inc...

NASDAQ: VTGN · Real-Time Price · USD
2.49
-0.14 (-5.32%)
At close: May 21, 2025, 12:08 PM

VistaGen Therapeutics Revenue

VistaGen Therapeutics reported an annual revenue of $1.06M, reflecting a 568.72% growth. For the quarter ending December 31, 2024, VistaGen Therapeutics generated $234K in revenue.
Revenue (ttm)
$1.06M
Revenue Growth
568.72%
Price / Sales Ratio
98.23
Revenue / Employee
$22.17K
Employees
48
Market Cap
71.87M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.